113. Between Scylla and Charybdis--Navigating Antimicrobial Resistance in Oncology and Transplantation
Friday, October 28, 2016: 8:30 AM-10:00 AM
Room: 391-392

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the approach to the transplant candidate colonized or infected with multi-drug resistant organisms
  • discuss variables to consider when evaluating immunocompromised patients with bacteremia caused by multi-drug resistant organisms
  • describe the impact of the use of antifungals in various settings on antifungal resistance rates and patient outcomes

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists

Tracks: Epidemiology and Infection Control, Adult ID, Global ID

Moderators:  David Van Duin, MD, PhD, University of North Carolina and Stephanie Pouch, MD, MS, The Ohio State University Wexner Medical Center

8:55 AM
9:00 AM
9:25 AM
9:55 AM

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-255-L01-P


D. Van Duin, astellas: Scientific Advisor , Consulting fee
tetraphase: Scientific Advisor , Consulting fee
actavis: Scientific Advisor , Consulting fee
medimmune: Scientific Advisor , Consulting fee
Sanofi-Pasteur: Scientific Advisor , Consulting fee
scynexis: Investigator , Research support
steris: Grant Investigator , Research grant

S. Pouch, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.